Skip to content

UNITED HEALTH PRODUCTS, INC.: 10-Q filed 2011-11-21

What UNITED HEALTH PRODUCTS, INC. reported in its quarterly report filed 2011-11-21 (fiscal Q3 2011): 18 published measures, 50 facts as tagged in accession 0001096938-11-000029.

This filing

Form
10-Q (quarterly report)
Filed
2011-11-21
Fiscal period
fiscal Q3 2011
Accession
0001096938-11-000029 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UNITED HEALTH PRODUCTS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-09-30358,363USD
At 2010-12-31390,398USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-09-30-1,005,561USD
At 2010-12-31-504,114USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-09-30728USD
At 2010-12-312,381USD
At 2010-09-3028,030USD
At 2009-12-318,018USD

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2011-07-01 to 2011-09-300USD92
2011-01-01 to 2011-09-300USD273
2010-07-01 to 2010-09-3033,610USD92
2010-01-01 to 2010-09-3069,071USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-09-30268,562USD273
2010-01-01 to 2010-09-30561,101USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-09-30-4,850USD273
2010-01-01 to 2010-09-300USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-09-30-5,547,567USD
At 2010-12-31-4,527,812USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-190,253USD92
2011-01-01 to 2011-09-30-979,426USD273
2010-07-01 to 2010-09-30-1,058,048USD92
2010-01-01 to 2010-09-30-2,361,830USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-09-3078,513USD
At 2010-12-3140,398USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-09-301,363,924USD
At 2010-12-31894,512USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-09-304,461,166USD
At 2010-12-313,943,270USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2011-09-3077,785USD
At 2010-12-3138,017USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2011-07-01 to 2011-09-30-208,042USD92
2011-01-01 to 2011-09-30-1,019,755USD273
2010-07-01 to 2010-09-30-1,062,499USD92
2010-01-01 to 2010-09-30-2,422,873USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-07-01 to 2011-09-30165,253USD92
2011-01-01 to 2011-09-30904,426USD273
2010-07-01 to 2010-09-301,026,329USD92
2010-01-01 to 2010-09-302,299,453USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2011-07-01 to 2011-09-3025,000USD92
2011-01-01 to 2011-09-3075,000USD273
2010-07-01 to 2010-09-3025,000USD92
2010-01-01 to 2010-09-3075,000USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2011-07-01 to 2011-09-3017,789USD92
2011-01-01 to 2011-09-3040,329USD273
2010-07-01 to 2010-09-304,451USD92
2010-01-01 to 2010-09-3011,656USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-300USD273
2010-01-01 to 2010-09-303,550USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-09-30189,872USD273
2010-01-01 to 2010-09-3089,959USD273

Inspect the source

Entity
UNITED HEALTH PRODUCTS, INC. / CIK 0001096938
Captured
2026-09-20T05:22:35.874Z
SEC response SHA-256
ac6cf9d703c0adca8f17a2c8b6ab295df7496239afbd8b7d9c595d23b1e2267e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001096938.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))